Alnylam Pharmaceuticals (ALNY) PT Raised to $180 at Needham & Company
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $227.62 +0.22%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company analyst Alan Carr raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $180.00 (from $160.00) while maintaining a Buy rating.
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $256 at Wells Fargo
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
